# ddcfDNA in Kidney Transplant Recipients

> **NCT06013358** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **GENETIC:** AlloSeq cfDNA

## Key facts

- **NCT ID:** NCT06013358
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-26
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-02-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06013358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06013358, "ddcfDNA in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06013358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*